Analgesics in Uruguay

Abstract
The COVID-19 pandemic contributed to growing levels of health consciousness in Uruguay, with consumers seeking better and preventive health care. Acetaminophen, commonly known as paracetamol, recorded rapid growth during the COVID-19 pandemic, as consumers sought to relieve the symptoms of the virus. Demand was fuelled by the government initially recommending the use of acetaminophen, rather than ibuprofen, to treat the symptoms of COVID-19. In addition, since the start of the COVID-19 vaccinati...

Euromonitor International's Analgesics in Uruguay report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Content
Analgesics in Uruguay

List Of Contents And Tables

ANALGESICS IN URUGUAY
KEY DATA FINDINGS
2022 DEVELOPMENTS
Acetaminophen continues to benefit from its status as the go-to treatment to relieve symptoms of COVID-19
Sluggish growth for ibuprofen, in view of lingering consumer health concerns
Bayer loses share following continuing consumer shift towards acetaminophen .
PROSPECTS AND OPPORTUNITIES
Acetaminophen will continue to grow, albeit at a slower rate, supported new product launches and lower prices
Demand for adult ibuprofen and adult aspirin expected to recover, amid a shift back to self-mediation
Infrastructure improvements offer strong growth potential for e-commerce
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2017-2022
Table 2 Sales of Analgesics by Category: % Value Growth 2017-2022
Table 3 NBO Company Shares of Analgesics: % Value 2018-2022
Table 4 LBN Brand Shares of Analgesics: % Value 2019-2022
Table 5 Forecast Sales of Analgesics by Category: Value 2022-2027
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN URUGUAY
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 8 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2017-2022
Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 13 Distribution of Consumer Health by Format: % Value 2017-2022
Table 14 Distribution of Consumer Health by Format and Category: % Value 2022
Table 15 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources